Enjoy complimentary customisation on priority with our Enterprise License!
The artificial pancreas market share is expected to increase by USD 450.95 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 19.15%.
This artificial pancreas market research report extensively covers artificial pancreas market segmentation by type (threshold suspend device, non-threshold suspend device, control to range system, and control to target system) and geography (North America, Europe, Asia, and ROW). The artificial pancreas market report also offers information on several market vendors, including Admetsys Corp., Beta Bionics Inc., Bigfoot Biomedical Inc., Defymed SAS, Dexcom Inc., Inreda Diabetic B.V., Insulet Corp., Medtech Life Pvt. Ltd., Medtronic Plc, and Tandem Diabetes Care Inc. among others.
Download the Free Report Sample to Unlock the Artificial Pancreas Market Size for the Forecast Period and Other Important Statistics
The rising global burden of diabetes is notably driving the artificial pancreas market growth, although factors such as stringent regulatory framework may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the artificial pancreas industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Artificial Pancreas Market Driver
One of the key factors driving growth in the artificial pancreas market is the rising global burden of diabetes. Diabetes is a chronic disease, which occurs when the body cannot use insulin effectively or when the pancreas does not produce enough insulin. Hyperglycemia or increased blood sugar can result in severe damage or complications that may become life-threatening for the individual if left untreated. The global burden of the disease is rising at a rapid pace. The growing incidence of both type 1 and type 2 diabetes will significantly increase healthcare costs across the world. The factors contributing to the increase in the diabetic population include obesity, smoking, a sedentary lifestyle, and growing urbanization. Furthermore, the incidence of diabetes is higher in the case of the older population. Countries with a higher population base like China and India are likely to have a higher incidence of diabetes owing to an increase in obesity levels and urbanization. Thus, the increasing incidence of diabetes worldwide is likely to drive the market with the increased adoption of an artificial pancreas.
Key Artificial Pancreas Market Trend
The increase in awareness programs for diabetes is another factor supporting the artificial pancreas market share growth. Vendors are organizing summits to spread awareness about diabetes as well as generate insights for product development. For instance, the European Foundation for the Study of Diabetes (EFSD) in Europe is a leading European funding agency for diabetes research, which aims at creating and spreading awareness of type 1 diabetes among people. The Juvenile Diabetes Research Foundation (JDRF) is fighting type 1 diabetes by funding research, advocating for policies that improve patient access to drugs, and providing a single support network for patients with type 1 diabetes. Various initiatives taken to increase the awareness of diabetes management in the region will also accelerate the growth of the market during the forecast period. Such initiatives provide participants with knowledge of various tools and daily routine activities for diabetes prevention, management, and control. This will further enhance the demand for artificial pancreas among diabetic patients, which, in turn, will drive the growth of the market.
Key Artificial Pancreas Market Challenge
The stringent regulatory framework will be a major challenge for the artificial pancreas market during the forecast period. Medical device-related regulations must be improved to ensure that high-quality, efficient, and safe technologies reach consumers. The growing number and modernization of medical devices have led to new regulatory challenges. The US FDA has classified diabetes care management devices, such as insulin pumps, infusion sets, and insulin bolus, under the Class II category of medical devices. Failure to adhere to the US FDA regulations or any complications caused by the use of artificial pancreas will lead to the recall of the product, which will significantly affect the company's brand name. In Europe and the US, regulations, including those for medical devices, focus on deploying robust surveillance systems, enhancing post-market regulations, strengthening the regulatory process, and improving monitoring of such devices. Market vendors that are focusing on adopting innovative technologies and designing novel products should undergo stringent post-market approvals prior to the launch of the products. Therefore, the stringent regulatory scenario could potentially hamper the artificial pancreas market.
This artificial pancreas market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global artificial pancreas market as a part of the global healthcare supplies market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the artificial pancreas market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the artificial pancreas market encompasses successful business strategies deployed by the key vendors. The artificial pancreas market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Admetsys Corp - The company offers artificial pancreas such as the closed-loop artificial pancreas.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The artificial pancreas market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the artificial pancreas market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the healthcare supplies market includes the following core components:
The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
***1. Executive Summary
**1.1 Market Overview
*Exhibit 01: Key Finding 1
*Exhibit 02: Key Finding 2
*Exhibit 03: Key Finding 3
*Exhibit 04: Key Finding 5
*Exhibit 05: Key Finding 6
*Exhibit 06: Key Finding 7
*Exhibit 07: Key Finding 8
***2. Market Landscape
**2.1 Market ecosystem
*2.1.1 Parent Market
*Exhibit 08 Parent market
*Exhibit 09: Market characteristics
**2.2 Value Chain Analysis
*Exhibit 10: Value Chain Analysis: Healthcare Supplies
*2.2.1 R&D
*2.2.2 Inputs
*2.2.3 Operations
*2.2.4 Outbound logistics
*2.2.5 Marketing and sales
*2.2.6 Post-sales and services
*2.2.7 Industry innovations
***3. Market Sizing
**3.1 Market definition
*Exhibit 11: Offerings of vendors included in the market definition
**3.2 Market segment analysis
*Exhibit 12: Market segments
**3.3 Market size 2021
**3.4 Market outlook: Forecast for 2021 - 2026
*3.4.1Estimating growth rates for emerging and high-growth markets
*3.4.2Estimating growth rates for mature markets
*Exhibit 13: Global - Market size and forecast 2021 - 2026 ($ million)
*Exhibit 14: Global market: Year-over-year growth 2021 - 2026 (%)
***4. Five Forces Analysis
**4.1 Five Forces Summary
*Exhibit 15: Five forces analysis 2021 - 2026
**4.2 Bargaining power of buyers
*Exhibit 16: Bargaining power of the buyer
**4.3 Bargaining power of suppliers
*Exhibit 17: Bargaining power of the supplier
**4.4 Threat of new entrants
*Exhibit 18: Threat of new entrants
**4.5 Threat of substitutes
*Exhibit 19: Threat of substitutes
**4.6 Threat of rivalry
*Exhibit 20: Threat of rivalry
**4.7 Market condition
*Exhibit 21: Market condition - Five forces 2021
***5. Market Segmentation by Type
**5.1 Market segments
*Exhibit 22: Type- Market share 2021 - 2026 (%)
**5.2 Comparison by Type
*Exhibit 23: Comparison by Type
**5.3 Threshold suspend device - Market size and forecast 2021-2026
*Exhibit 24: Threshold suspend device - Market size and forecast 2021-2026 ($ million)
*Exhibit 25: Threshold suspend device - Year-over-year growth 2021-2026 (%)
**5.4 Non-threshold suspend device - Market size and forecast 2021-2026
*Exhibit 26: Non-threshold suspend device - Market size and forecast 2021-2026 ($ million)
*Exhibit 27: Non-threshold suspend device - Year-over-year growth 2021-2026 (%)
**5.5 Control to range system - Market size and forecast 2021-2026
*Exhibit 28: Control to range system - Market size and forecast 2021-2026 ($ million)
*Exhibit 29: Control to range system - Year-over-year growth 2021-2026 (%)
**5.6 Control to target system - Market size and forecast 2021-2026
*Exhibit 30: Control to target system - Market size and forecast 2021-2026 ($ million)
*Exhibit 31: Control to target system - Year-over-year growth 2021-2026 (%)
**5.7 Market opportunity by Type
*Exhibit 32: Market opportunity by Type
***6. Customer landscape
*Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
**6.1 Overview
*Exhibit 33: Customer landscape
***7. Geographic Landscape
**7.1 Geographic segmentation
*Exhibit 34: Market share by geography 2021-2026 (%)
**7.2 Geographic comparison
*Exhibit 35: Geographic comparison
**7.3 North America - Market size and forecast 2021-2026
*Exhibit 36: North America - Market size and forecast 2021-2026 ($ million)
*Exhibit 37: North America - Year-over-year growth 2021-2026 (%)
**7.4 Europe - Market size and forecast 2021-2026
*Exhibit 38: Europe - Market size and forecast 2021-2026 ($ million)
*Exhibit 39: Europe - Year-over-year growth 2021-2026 (%)
**7.5 Asia - Market size and forecast 2021-2026
*Exhibit 40: Asia - Market size and forecast 2021-2026 ($ million)
*Exhibit 41: Asia - Year-over-year growth 2021-2026 (%)
**7.6 ROW - Market size and forecast 2021-2026
*Exhibit 42: ROW - Market size and forecast 2021-2026 ($ million)
*Exhibit 43: ROW - Year-over-year growth 2021-2026 (%)
**7.7 Key leading countries
*Exhibit 44: Key leading countries
**7.8 Market opportunity by geography
*Exhibit 45: Market opportunity by geography ($ million)
***8. Drivers, Challenges, and Trends
**8.1 Market drivers
*8.1.1 Rising global burden of diabetes
*Exhibit 46: Prevalence of diabetes 2000 and 2030 (million)
*8.1.2 Favorable regulations and guidelines
*8.1.3 Rising geriatric population
**8.2 Market challenges
*8.2.1 Stringent regulatory framework
*8.2.2 Low penetration rates
*8.2.3 High cost of artificial pancreas
*Exhibit 47: Impact of drivers and challenges
**8.3 Market trends
*8.3.1 Increase in awareness programs for diabetes
*8.3.2 Growing technological integration
*8.3.3 Rising strategic partnerships to boost sales of artificial pancreas
***9. Vendor Landscape
**9.1 Overview
*Exhibit 48: Vendor landscape
**9.2 Landscape disruption
*Exhibit 49: Landscape disruption
*Exhibit 50: Industry Risk
***10. Vendor Analysis
**10.1 Vendors covered
*Exhibit 51: Vendors covered
**10.2 Market positioning of vendors
*Exhibit 52: ?Market positioning of vendors?
**10.3 Admetsys Corp.
*Exhibit 53: Admetsys Corp. - Overview
*Exhibit 54: Admetsys Corp. - Product and service
*Exhibit 55: Admetsys Corp. - Key offerings
**10.4 Beta Bionics Inc.
*Exhibit 56: Beta Bionics Inc. - Overview
*Exhibit 57: Beta Bionics Inc. - Business segments
*Exhibit 58: Beta Bionics Inc. - Key news
*Exhibit 59: Beta Bionics Inc. - Key offerings
*Exhibit 60: Beta Bionics Inc. - Segment focus
**10.5 Bigfoot Biomedical Inc.
*Exhibit 61: Bigfoot Biomedical Inc. - Overview
*Exhibit 62: Bigfoot Biomedical Inc. - Product and service
*Exhibit 63: Bigfoot Biomedical Inc. - Key offerings
**10.6 Defymed SAS
*Exhibit 64: Defymed SAS - Overview
*Exhibit 65: Defymed SAS - Product and service
*Exhibit 66: Defymed SAS - Key offerings
**10.7 Dexcom Inc.
*Exhibit 67: Dexcom Inc. - Overview
*Exhibit 68: Dexcom Inc. - Business segments
*Exhibit 69: Dexcom Inc. - Key offerings
*Exhibit 70: Dexcom Inc. - Segment focus
**10.8 Inreda Diabetic B.V.
*Exhibit 71: Inreda Diabetic B.V. - Overview
*Exhibit 72: Inreda Diabetic B.V. - Product and service
*Exhibit 73: Inreda Diabetic B.V. - Key offerings
**10.9 Insulet Corp.
*Exhibit 74: Insulet Corp. - Overview
*Exhibit 75: Insulet Corp. - Business segments\
*Exhibit 76: Insulet Corp. - Key offerings
*Exhibit 77: Insulet Corp. - Segment focus
**10.10 Medtech Life Pvt. Ltd.
*Exhibit 78: Medtech Life Pvt. Ltd. - Overview
*Exhibit 79: Medtech Life Pvt. Ltd. - Product and service
*Exhibit 80: Medtech Life Pvt. Ltd. - Key offerings
**10.11 Medtronic Plc
*Exhibit 81: Medtronic Plc - Overview
*Exhibit 82: Medtronic Plc - Business segments
*Exhibit 83: Medtronic Plc - Key offerings
*Exhibit 84: Medtronic Plc - Segment focus
**10.12 Tandem Diabetes Care Inc.
*Exhibit 85: Tandem Diabetes Care Inc. - Overview
*Exhibit 86: Tandem Diabetes Care Inc. - Business segments
*Exhibit 87: Tandem Diabetes Care Inc. - Key offerings
*Exhibit 88: Tandem Diabetes Care Inc. - Segment focus
***11. Appendix
**11.1 Scope of the report
*11.1.1 ????Market definition
*11.1.2 ????Objectives
*11.1.3 ????Notes and caveats
**11.2 Currency conversion rates for US$
*Exhibit 89: ?Currency conversion rates for US$?
**11.3 Research Methodology
*Exhibit 90: ?Research Methodology
*Exhibit 91: ??Validation techniques employed for market sizing?
*Exhibit 92: ??Information sources
**11.4 List of abbreviations
*Exhibit 93: List of abbreviations
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.